Insiders sold 165K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. SVP, Chief Commercial Officer Kerr Holbrook sold 165K on Nov 18, 2025, 15% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.
Get an email when AVNS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Kerr Holbrook SVP, Chief Commercial Officer | SoldNo plan 4 parts | 15,000 | $11.00 average | 165K | 15% | Form 4 |
| Aug 13, 2025 | Gary Blackford Director | Bought 2 parts | 60,000 | $10.99 average | 660K | 84% | Form 4 |
| Mar 6, 2025 | Kerr Holbrook SVP, Chief Commercial Officer | SoldNo plan | 7,000 | $15.25 | 107K | 8.4% | Form 4 |
- Nov 18, 2025No planKerr HolbrookSVP, Chief Commercial Officer · sold 15,000 at avg $11.00165K15% of stake
- Aug 13, 2025Gary BlackfordDirector · bought 60,000 at avg $10.99660K84% of stake
- Mar 6, 2025No planKerr HolbrookSVP, Chief Commercial Officer · sold 7,000 at $15.25107K8.4% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with AVNS
Held by ETFs
AVNS is in 15 US ETFs. The largest of them, with AVNS's weight in each:
Avantis U.S. Small Cap Value ETFAVUV0.00%of the fund
Fidelity Enhanced Small Cap ETFFESM0.03%of the fund
Avantis U.S. Small Cap Equity ETFAVSC0.09%of the fund
Principal U.S. Small-Cap ETFPSC0.07%of the fund
Invesco S&P SmallCap 600 Revenue ETFRWJ0.08%of the fund
Thrivent Small-Mid Cap Equity ETFTSME1.39%of the fund
Spot a number that looks wrong? Check it in AVNS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVNS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.